United Therapeutics Corporation (UTHR)
Total asset turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 2,877,400 | 2,327,500 | 1,936,300 | 1,685,500 | 1,483,300 |
Total assets | US$ in thousands | 7,364,000 | 7,167,000 | 6,044,500 | 5,169,100 | 4,615,000 |
Total asset turnover | 0.39 | 0.32 | 0.32 | 0.33 | 0.32 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $2,877,400K ÷ $7,364,000K
= 0.39
The total asset turnover ratio for United Therapeutics Corporation has shown a slight increase over the years, from 0.32 in December 31, 2020, to 0.39 in December 31, 2024. This indicates that the company generated more revenue for each dollar of assets during this period. However, it is important to note that the ratio has fluctuated slightly over the years, indicating potential variations in the efficiency of asset utilization. Overall, the increasing trend in total asset turnover suggests improved efficiency in generating sales relative to the company's total assets.
Peer comparison
Dec 31, 2024
Company name
Symbol
Total asset turnover
United Therapeutics Corporation
UTHR
0.39
Abbott Laboratories
ABT
0.52
AbbVie Inc
ABBV
0.42
ACADIA Pharmaceuticals Inc
ACAD
0.81
Alkermes Plc
ALKS
0.76
Amphastar P
AMPH
0.46
ANI Pharmaceuticals Inc
ANIP
0.48
Arcus Biosciences Inc
RCUS
0.22
Biomarin Pharmaceutical Inc
BMRN
0.41
Bristol-Myers Squibb Company
BMY
0.52
Catalyst Pharmaceuticals Inc
CPRX
0.58